Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Study of glucocorticoid-receptor interactions may lead to new anti-asthma agents
September 1st, 2003
Studies on the binding of glucocorticoids to the receptor and subsequent activity may lead to new and better anti-asthma agents. "Glucocorticoids are widely used to treat inflammatory and immune diseases. The most common use of glucocorticoids today is in the treatment of asthma. Inhaled glucocorticoids are first line treatment in adults and children with persistent asthma, the most common chronic airway inflammatory disease," researchers in England report. "Our knowledge of how glucocorticoids suppress inflammation is based on recent developments in understanding the fundamental mechanisms of gene transcription, namely recruitment of histone...
Source: Health & Medicine Week (2003-09-01)
|
